TrialEuropean journal of clinical pharmacology2013

A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail.

Peter N Morcos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.